(Q61865985)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19134234%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Markov modelling of HIV infection evolution in the HAART era (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19134234%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

C Binquet

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19134234%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

G Le Teuff

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19134234%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

M Abrahamovicz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19134234%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

A Mahboubi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19134234%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

D Rey

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19134234%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

C Rabaud

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19134234%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

C Chirouze

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19134234%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

J L Berger

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19134234%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

J P Faller

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19134234%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

P Chavanet

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19134234%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

L Piroth

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19134234%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Groupe InterCOrevih du Nord-Est (ICONE)

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19134234%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

12 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19134234%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology and Infection

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19134234%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

137

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19134234%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19134234%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

1272-1282

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19134234%20AND%20SRC:MED&resulttype=core&format=json

Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0950268808001775

7 January 2021

Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1017%2FS0950268808001775

7 January 2021

CD4 Cell Counts of 800 Cells/mm3 or Greater After 7 Years of Highly Active Antiretroviral Therapy Are Feasible in Most Patients Starting With 350 Cells/mm3 or Greater

1 reference

https://api.crossref.org/works/10.1017%2FS0950268808001775

7 January 2021

Weight loss as a predictor of survival and disease progression in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS.

1 reference

https://api.crossref.org/works/10.1017%2FS0950268808001775

7 January 2021

Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study

1 reference

https://api.crossref.org/works/10.1017%2FS0950268808001775

7 January 2021

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1017%2FS0950268808001775

7 January 2021

Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort

1 reference

https://api.crossref.org/works/10.1017%2FS0950268808001775

7 January 2021

Long-term clinical benefit after highly active antiretroviral therapy in advanced HIV-1 infection, even in patients without immune reconstitution

1 reference

https://api.crossref.org/works/10.1017%2FS0950268808001775

7 January 2021

Timing of antiretroviral therapy. Use of Markov modeling and decision analysis to evaluate the long-term implications of therapy.

1 reference

https://api.crossref.org/works/10.1017%2FS0950268808001775

7 January 2021

Modeling recurrence in colorectal cancer

1 reference

https://api.crossref.org/works/10.1017%2FS0950268808001775

7 January 2021

Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol

1 reference

https://api.crossref.org/works/10.1017%2FS0950268808001775

7 January 2021

Comparison of smoothing techniques for CD4 data in a Markov model with states defined by CD4: an example on the estimation of the HIV incubation time distribution

1 reference

https://api.crossref.org/works/10.1017%2FS0950268808001775

7 January 2021

Modeling the Time Course of CD4 T-Lymphocyte Counts According to the Level of Virologic Rebound in HIV-1–Infected Patients on Highly Active Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1017%2FS0950268808001775

7 January 2021

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

1 reference

https://api.crossref.org/works/10.1017%2FS0950268808001775

7 January 2021

MKVPCI: a computer program for Markov models with piecewise constant intensities and covariates

1 reference

https://api.crossref.org/works/10.1017%2FS0950268808001775

7 January 2021

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.

1 reference

https://api.crossref.org/works/10.1017%2FS0950268808001775

7 January 2021

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.

1 reference

https://api.crossref.org/works/10.1017%2FS0950268808001775

7 January 2021

1998 revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. BHIVA Guidelines Writing Committee

1 reference

https://api.crossref.org/works/10.1017%2FS0950268808001775

7 January 2021

Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1017%2FS0950268808001775

7 January 2021

Time-updated CD4+ T lymphocyte count and HIV RNA as major markers of disease progression in naive HIV-1-infected patients treated with a highly active antiretroviral therapy: the Aquitaine cohort, 1996-2001

1 reference

https://api.crossref.org/works/10.1017%2FS0950268808001775

7 January 2021

British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2005).

1 reference

https://api.crossref.org/works/10.1017%2FS0950268808001775

7 January 2021

Hospitalization Rates Differ by Hepatitis C Status in an Urban HIV Cohort

1 reference

https://api.crossref.org/works/10.1017%2FS0950268808001775

7 January 2021

Markov Chains With Measurement Error: Estimating the `True' Course of a Marker of the Progression of Human Immunodeficiency Virus Disease

1 reference

https://api.crossref.org/works/10.1017%2FS0950268808001775

7 January 2021

Increasing risk of 5% or greater unintentional weight loss in a cohort of HIV-infected patients, 1995 to 2003.

1 reference

https://api.crossref.org/works/10.1017%2FS0950268808001775

7 January 2021

Time to hit HIV, early and hard.

1 reference

https://api.crossref.org/works/10.1017%2FS0950268808001775

7 January 2021

Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1017%2FS0950268808001775

7 January 2021

Use of the Markov model to estimate the waiting times in a modified WHO staging system for HIV infection

1 reference

https://api.crossref.org/works/10.1017%2FS0950268808001775

7 January 2021

MARKOV: A computer program for multi-state Markov models with covariables

1 reference

https://api.crossref.org/works/10.1017%2FS0950268808001775

7 January 2021

Physical activity, physical fitness, and risk of dying.

1 reference

https://api.crossref.org/works/10.1017%2FS0950268808001775

7 January 2021

Modeling changes in CD4-positive T-lymphocyte counts after the start of highly active antiretroviral therapy and the relation with risk of opportunistic infections: the Aquitaine Cohort, 1996-1997

1 reference

https://api.crossref.org/works/10.1017%2FS0950268808001775

7 January 2021

Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring

1 reference

https://api.crossref.org/works/10.1017%2FS0950268808001775

7 January 2021

10.1017/S0950268808001775

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19134234%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference